// App-Quantinova.ai

e19206 : Associations between safety and tolerability and reporting of health-related quality of life in phase III randomized trials in common solid tumors.

Researchers

Presenter

  • Ramy Saleh

Principal Investigators

  • Nick Meti

  • Domen Ribnikar

  • Hadar Goldvaser

  • Alberto Ocana

  • Arnoud J. Templeton

  • Bostjan Seruga

  • Eitan Amir

Medical Centers

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • McGill, Montreal, QC, Canada

  • Institute of Oncology Ljubljana, Ljubljana, Slovenia

  • Rabin Medical Center, Beilinson Hospital, Davidoff Center, Petach Tikva, Israel

  • Department of Medical Oncology, St. Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland

  • Institute of Oncology Ljubljana, Ljubljana, Slovenia

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

  • Slovenia

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A